These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26169622)

  • 1. Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis.
    Ngeow J; Liu C; Zhou K; Frick KD; Matchar DB; Eng C
    J Clin Oncol; 2015 Aug; 33(23):2537-44. PubMed ID: 26169622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
    Ngeow J; Eng C
    Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
    Mester JL; Moore RA; Eng C
    Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
    Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
    Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.
    Tan MH; Mester J; Peterson C; Yang Y; Chen JL; Rybicki LA; Milas K; Pederson H; Remzi B; Orloff MS; Eng C
    Am J Hum Genet; 2011 Jan; 88(1):42-56. PubMed ID: 21194675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
    Bennett KL; Mester J; Eng C
    JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
    Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experience with analysis of the PTEN gene in patients suspected of having Cowden syndrome].
    Vasovcák P; Foretová L; Puchmajerová A; Senkeríková M; Martínek J; Krepelová A
    Klin Onkol; 2010; 23(2):111-4. PubMed ID: 20465090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
    Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
    J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.
    Mahdi H; Mester JL; Nizialek EA; Ngeow J; Michener C; Eng C
    Cancer; 2015 Mar; 121(5):688-96. PubMed ID: 25376524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
    Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
    J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline PTEN mutations in Cowden syndrome-like families.
    Marsh DJ; Dahia PL; Caron S; Kum JB; Frayling IM; Tomlinson IP; Hughes KS; Eeles RA; Hodgson SV; Murday VA; Houlston R; Eng C
    J Med Genet; 1998 Nov; 35(11):881-5. PubMed ID: 9832031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
    Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Germline
    Lopez C; Abuel-Haija M; Pena L; Coppola D
    Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
    Tate G; Suzuki T; Endo Y; Mitsuya T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.